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Isolation and structure determination of new compounds 
from Baeckea frutescens collected in Indonesia and their 
antibacterial and cytotoxic activities 
(インドネシア産フトモモ科植物 Baeckea frutescens 由来
の新規化合物の単離・構造決定と抗菌活性及び細胞毒性) 
Introduction 
Natural products have been an integral part in drug discovery. About 51% of new drugs developed 
between 1981 and 2013 were based on the structure of natural products. Thus, investigating of the 
bioactive compounds from natural resources still attracts our attention to drug discovery. 
Indonesia consists of more than 18,000 islands, including Sumatra, Java, Kalimantan, and 
Sulawesi. Around two-thirds of the area is still covered with tropical rainforests, and over 38,000 
species of tropical plants can be found in Indonesia. Among these, 7,000 species of medicinal plants 
have been used as Indonesian traditional medicine “Jamu”. A great number of biologically active 
metabolites have been reported from Indonesian medicinal plants during a couple of decades. However, 
most of natural product resources have remained to be fully investigated. Therefore, exploratory 
research for novel biological active components from diverse medicinal plants in Indonesia will 
contribute to discover new pharmaceutical leads and candidates, as well as the development of new 
drugs in order to treat various diseases. This study aims to isolate new compounds, mainly by focusing 
on antibacterial activity since the antibiotic resistance of human pathogenic microorganisms is still a 
global concern.  
1. Antibacterial screening of Indonesian medicinal plants
The crude MeOH and CHCl3 extracts were prepared from twenty-six Indonesian medicinal plants 
obtained in different places. These extracts were screened for their antibacterial activities against three 
Gram-positive bacterial strains, Bacillus subtilis NBRC 3134, Staphylococcus aureus NBRC 15035, 
and Mycobacterium smegmatis NBRC 3082, and two Gram-negative bacterial strains, Escherichia coli 
NBRC 102203 and Klebsiella pneumoniae NBRC 3512. The antibacterial activity was determined 
using the standard 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide (MTT) assay method. 
The minimum inhibitory concentration (MIC) value of the crude extracts was defined as the lowest 
concentration showed no visible bacterial growth after incubation at 37°C for 24 h. The antibacterial 
assays revealed that the CHCl3 extracts of B. frutescens leaves and C. mangga rhizome showed weak 
activities against S. aureus with an MIC value of 100 µg/mL and 200 µg/mL, respectively (Table 1). In 
contrast, those of B. frutescens leaves and C. mangga rhizome exhibited antibacterial activities against 
B. subtilis with an MIC value of 200 µg/mL and 150 µg/mL, respectively. 
2. Constituents of the leaves of Baeckea frutescens collected in Indonesia
The leaves of B. frutescens L. (Myrtaceae), popularly known as “Jungrahab”, have been broadly 
utilized as a traditional folk medicine for a long time to treat fever and rheumatism in South East Asia, 
Australia, and Southern China. This plant is also known to possess anti-inflammatory, antipyretic, 
antidysentery, antibacterial, and cytotoxic activities. Previous phytochemical investigations of B. 
frutescens resulted in the isolation of phloroglucinols, sesquiterpenes, flavanones, tasmanones, 
chromones, and chromanones. Since the CHCl3 extract of B. frutescens leaves exhibited the most potent 
antibacterial activity, the extract was selected and was subjected to further isolation of the bioactive 
compounds. 
The leaves of B. frutescens were extracted with CHCl3 under sonication at room temperature. The 
resulting CHCl3 extract was subjected to silica gel Medium Pressure Liquid Chromatography (MPLC) 
with an n-hexane-EtOAc gradient solvent system to yield 10 fractions. The fractions were further 
separated by a series of chromatographic methods to furnish twelve new compounds (Figure 1) 
including nine phloroglucinol-type metabolites, baeckenones A−I (1−6, 10−12), two cyclopentenone 
derivatives, frutescencenones A and B (7 and 8), and a furanone derivative, frutescencenone C (9), 
along with ten known compounds (13−22) (Figure 2). The structures of all new compounds were 
elucidated on the basis of physicochemical data such as HRMS and 1D and 2D NMRs. Among the 
known compounds, 4-hydroxy-2,2,5-trimethyl-cyclopent-4-ene-1,3-dione (16) has been isolated for the 
first time as a natural product.  
The unique phloroglucinols have been isolated from the family Myrtaceae plants. The structures of 
baeckenones D, E, and G (4, 5, and 10) demonstrated unique acylphloroglucinol skeletons with 
endo-peroxide linkage, as in the case of 14. Baeckenones D (4) and E (5) were isolated as a 
diastereoisomer in racemic mixtures. The relative structure of baeckenone D was determined by the 
X-ray crystallographic analysis and NOESY experiments. I propose that baeckenone D (4) and 
baeckenone E (5) would be derived from a biosynthetic precursor (i) via a keto-enol tautomerization of 
the precursor for the formation of two diene intermediates (iia and iib) and a singlet oxygen 
(1O2)-involving Diels-Alder type cyclization of each intermediate for the formation of baeckenone D (4) 
and baeckenone E (5), respectively (Scheme 1). 
3. Biological activities of constituents isolated from Baeckea frutescens
The antibacterial activities of the isolated compounds (1−22) against B. subtilis, S. aureus, M. 
smegmatis, E. coli, and K. pneumoniae were assessed by using the standard microdilution methods. All 
compounds were inactive against the Gram-negative bacterial strains, E. coli and K. pneumoniae. In 
contrast, only baeckenone B (2) had good antibacterial activities against the Gram-positive bacterial 
strains, B. subtilis and S. aureus with MIC values of 40 µM and 50 µM, respectively. 
The phloroglucinol derivatives reportedly exhibit cytotoxic activities against cancer cell lines such 
as breast and leukemia cells. Therefore, cytotoxic activities of the isolated compounds (1−22) were also 
assessed against human pancreatic (PSN-1), human lung (A549), and breast (MDA-MB231) cancer cell 
lines. The cytotoxic activities were evaluated by using the standard WST-8 assay method. 5-fluorouracil 
was used as a positive control. Baeckenone F (6) showed moderate growth inhibitory activities, with 
half maximal inhibitory concentration (IC50) values ranging from 33.3 μM to 39.3 μM against three 
tested cell lines. Baeckenone D (4) and the known endoperoxide-type phloroglucinol (14) exhibited 
selectively weak growth inhibitory activities against the A549 cancer cell line. Frutescencenone A (7) 
exhibited significant cytotoxic effects against the three cancer cell lines, human lung A549, pancreatic 
PSN-1, and breast MDA-MB-231, with IC50 values of 36.3, 29.3, and 38.2 μM, respectively. In 
contrast, a new furanone, frutescencenone C (9), showed selective cytotoxic activity against the PSN-1 
cell line, with an IC50 value of 20.1 μM (Table 2). 
 
Conclusion 
In this study, CHCl3 and MeOH soluble-portions prepared from twenty-six traditional medicinal 
plants were screened for their antibacterial activity. Among these, the CHCl3 extract of the leaves of B. 
frutescens showed the highest antibacterial activity. The phytochemical investigation and 
bioassay-guided separation of the leaves of B. frutescens led to the isolation of twelve new compounds 
consisting nine phloroglucinols (1−6, 10−12), two cyclopentenones (7, 8), and a furanone (9), together 
with ten known compounds (13−22). Among the isolated compounds, new acylphloroglucinol, 
baeckenone B (2), showed antibacterial activity against B. subtillis and S. aureus with the MIC values of 
40 µM and 50 µM, respectively. On the other hand, baeckenone F (6) and frutescencenones A and C (7 
and 9) exhibited growth inhibitory activities against several cancer cell lines. A large number of 
phloroglucinol-producing plants have been used in traditional medicine throughout the world. 
Phloroglucinols and the related metabolites have been reported that these compounds possess a wide 
range of biological effects, such as antibacterial, antifungal, antiplasmodial, and antimalarial activities. 
Further elucidation of the bioactivity of the compounds obtained in this study may suggest key lead(s) 
in the development of new drugs. 
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Table 1. Antibacterial activities of CHCl3 extracts from B. frutescens and C. mangga  
Plant extracts MIC (µg/mL) 
S. aureus M. smegmatis B. subtilis K. pneumoniae E. coli 
Baeckea frutescens 100 > 200 200 > 200 > 200 
Curcuma mangga 200 > 200  150 > 200 > 200 
Ampicillin a   0.1     0.1    0.1      0.1   0.1 
a Positive control 
 
 
Figure 1. Structure of new compounds isolated from the CHCl3 extract of B. frutescens leaves 
 
Figure 2. Structure of known compounds isolated from the CHCl3 extract of B. frutescens leaves 
 Scheme 1. Proposed racemic formation of baeckenone D and baeckenone E 
 
Table 2. Cytotoxic activities of some compounds isolated from B. frutescens leaves 
Compound  IC50 (µM) 
A549 PSN-1 MDA-MB-231 
Baeckenone D 60.0 > 100 > 100 
Baeckenone F 34.0 33.3 39.3 
Frutescencenone A 36.3 29.3 38.2 
Frutescencenone C 88.0 20.1 > 100 
5-FU a  1.8  2.4  4.0 
a 5-Florouracil (5-FU): Positive control 
 
 
